In the present study, findings revealed that flavokawain C exhibited a predilection for in vivo accumulation in liver tissues with minimal impact on normal liver tissue, and concurrently exerted substantial inhibitory effects on the proliferation and migration of liver cancer cells in vitro and in vivo by downregulating the FAK/PI3K/AKT pathway. This evidence concerns the gene AKT1 and liver cancer.